In the BioHarmony Drug Report Database

"Preview" Icon

Betamethasone

Celestone, Neofordex, Ozurdex (betamethasone) is a small molecule pharmaceutical. Betamethasone was first approved as Celestone on 1982-01-01. It is used to treat atopic dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, and inflammation amongst others in the USA. It has been approved in Europe to treat macular edema, multiple myeloma, and uveitis. The pharmaceutical is active against glucocorticoid receptor.

 

Trade Name

 

Neofordex, Ozurdex
 

Common Name

 

betamethasone
 

ChEMBL ID

 

CHEMBL632
 

Indication

 

atopic dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, macular edema, multiple myeloma, pruritus ani, psoriasis, scalp dermatoses, seborrheic dermatitis, uveitis
 

Drug Class

 

Image (chem structure or protein)

Betamethasone structure rendering